Deuterium-enriched alkyl sulfonamides
First Claim
Patent Images
1. A deuterium-enriched compound of formula I and II, or the pharmaceutically acceptable salt thereof, wherein:
- R1-R34 of formula I are independently selected from H and D;
R1-R38 of formula II are independently selected from H and D;
R25 in both formula I and II is independently selected from H, D and CD3;
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention is concerned with deuterium-enriched isobutyl and cyclohexylmethyl sulfonamides of formula I and II, and pharmaceutically acceptable salts and methods of use thereof for the treatment of general anxiety disorders, major depressive disorders, attention deficit disorders, attention deficit hyperactivity disorder, Alzheimer'"'"'s disease, frontotemporal dementia, cognitive impairment associated with age-related dementia, schizophrenia, migraine, sleep disorders, neurodegenerative diseases and obesity.
-
Citations
7 Claims
-
1. A deuterium-enriched compound of formula I and II, or the pharmaceutically acceptable salt thereof, wherein:
-
R1-R34 of formula I are independently selected from H and D; R1-R38 of formula II are independently selected from H and D; R25 in both formula I and II is independently selected from H, D and CD3; - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
Specification